Lurbinectedin
Back to searchMolecule Structure
Scientific Name
Lurbinectedin
Description of the Drug
Lurbinectedin is a chemotherapeutic DNA alkylating agent used in the treatment of metastatic small-cell lung cancer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12674
http://www.drugbank.ca/drugs/DB12674
Brand Name(s)
Zepsyre, Zepzelca
Company Owner(s)
Jazz Pharmaceuticals Ireland Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA | NUCLEIC-ACID | NEGATIVE MODULATOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16152477 | |
| DrugBank | DB12674 | |
| PubChem | 57327016 | |
| Nikkaji | J3.652.626B | J3.531.659K |
| EPA CompTox Dashboard | DTXSID30198065 | |
| DrugCentral | 5398 | |
| ChemicalBook | CB82628057 | |
| Guide to Pharmacology | 10681 | |
| rxnorm | LURBINECTEDIN |
